Zimmer Biomet Holdings Management

Management Kriterienprüfungen 3/4

Zimmer Biomet Holdings CEO ist Ivan Tornos , ernannt in Mar 2021, hat eine Amtszeit von 3.67 Jahren. Die jährliche Gesamtvergütung beträgt $10.19M , bestehend aus 9.5% Gehalt und 90.5% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.013% der Aktien des Unternehmens, im Wert von $2.92M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.7 Jahre bzw. 6.3 Jahre.

Wichtige Informationen

Ivan Tornos

Geschäftsführender

US$10.2m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts9.5%
Amtszeit als Geschäftsführer3.7yrs
Eigentum des Geschäftsführers0.01%
Durchschnittliche Amtszeit des Managements3.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.3yrs

Jüngste Management Updates

Recent updates

Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Nov 07
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 02
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up

Oct 03
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up

Zimmer Biomet: The Undervalued Titan Of Joint Replacements

Oct 02

Zimmer Biomet Stock: Don't Jump In At The 52-Week Low

Sep 19

We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)

Sep 18
We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

Sep 02
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly

Aug 27
Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly

Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?

Jul 15
Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?

Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings

Jul 02
Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings

Zimmer Biomet: Brighter Prospects In H2 2024

Jul 02

Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24

Jun 19
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24

When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Jun 05
When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

May 21
Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Zimmer Biomet Holdings: Moving Along

May 17

The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising

May 02
The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising

Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

Mar 20
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24

Mar 02
Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24

Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality

Feb 15
Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality

What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?

Feb 11
What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?

Zimmer Biomet: Weight Loss Drug Concerns Are Overblown

Feb 05

A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Jan 29
A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'

Jan 20

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar

Jan 15
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar

The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing

Dec 31
The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing

Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution

Dec 18

Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Dec 17
Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Zimmer Biomet: Still Many Questions After A Solid Year So Far

Nov 26

When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Nov 06
When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching

Oct 07
Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching

Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes

Sep 21
Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes

Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence

Sep 14

Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Sep 06
Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy

Aug 11

Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?

Aug 08
Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?

Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?

Jul 10
Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?

We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease

Jun 27
We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease

Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement

Jun 13
Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement

A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

May 30
A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Expect Growth Momentum To Continue

May 26

Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

May 04
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Ivan Tornos im Vergleich zu den Einnahmen von Zimmer Biomet Holdings verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

US$1b

Jun 30 2024n/an/a

US$997m

Mar 31 2024n/an/a

US$964m

Dec 31 2023US$10mUS$969k

US$1b

Sep 30 2023n/an/a

US$474m

Jun 30 2023n/an/a

US$506m

Mar 31 2023n/an/a

US$450m

Dec 31 2022US$6mUS$823k

US$290m

Sep 30 2022n/an/a

US$366m

Jun 30 2022n/an/a

US$334m

Mar 31 2022n/an/a

US$325m

Dec 31 2021US$5mUS$731k

US$445m

Sep 30 2021n/an/a

US$834m

Jun 30 2021n/an/a

US$914m

Mar 31 2021n/an/a

US$563m

Dec 31 2020US$4mUS$730k

-US$11m

Sep 30 2020n/an/a

-US$152m

Jun 30 2020n/an/a

US$37m

Mar 31 2020n/an/a

US$377m

Dec 31 2019US$4mUS$700k

US$1b

Sep 30 2019n/an/a

-US$90m

Jun 30 2019n/an/a

-US$359m

Mar 31 2019n/an/a

-US$308m

Dec 31 2018US$4mUS$113k

-US$379m

Vergütung im Vergleich zum Markt: IvanDie Gesamtvergütung ($USD10.19M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD12.73M).

Entschädigung vs. Einkommen: IvanDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.


Geschäftsführer

Ivan Tornos (49 yo)

3.7yrs

Amtszeit

US$10,191,476

Vergütung

Mr. Ivan Tornos serves as Independent External Director at PHC Holdings Corporation since September 03, 2021. He joined PHC Holdings Corporation on September 03, 2021. Mr. Tornos serves as Chief Operating...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Ivan Tornos
COO, President3.7yrsUS$10.19m0.013%
$ 2.9m
Suketu Upadhyay
CFO and Executive VP of Finance5.3yrsUS$10.38m0.015%
$ 3.2m
Chad Phipps
Senior VP17.5yrsUS$2.87m0.025%
$ 5.4m
Sang Yi
President of Asia Pacific9.4yrsUS$3.38m0.0027%
$ 580.7k
Wilfred van Zuilen
Group President of Europe3.4yrsUS$3.42m0.0046%
$ 1.0m
Paul Stellato
VP, Controller & Chief Accounting Officer2.5yrskeine Daten0.00069%
$ 150.1k
Shaun Braun
Senior VP & Chief Information and Technology Officerless than a yearkeine Datenkeine Daten
Rachel Ellingson
Senior VP & Chief Administrative Officerless than a yearkeine Daten0.0034%
$ 748.2k
David DeMartino
Senior VP of Investor Relationsless than a yearkeine Datenkeine Daten
Angela Main
Senior VP9.4yrskeine Datenkeine Daten
Lori Winkler
Senior VP & Chief Human Resources Officer3.8yrskeine Daten0.0017%
$ 365.4k
David Kunz
Senior Vice President of Global Quality & Regulatory Affairs7.3yrskeine Datenkeine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrenes Management: ZBHDas Führungsteam des Unternehmens gilt als erfahren (3.7 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Ivan Tornos
COO, President1.3yrsUS$10.19m0.013%
$ 2.9m
Christopher Begley
Independent Chairman of the Board12.3yrsUS$409.38k0.0018%
$ 387.1k
Betsy Bernard
Independent Director15.8yrsUS$340.26k0.0027%
$ 576.4k
Robert Hagemann
Independent Director16.7yrsUS$358.20k0.0020%
$ 437.2k
Arthur Higgins
Independent Director17.8yrsUS$347.75k0.0017%
$ 371.9k
Louis Shapiro
Directorless than a yearkeine Datenkeine Daten
Maria Hilado
Independent Director6.3yrsUS$314.44k0.00083%
$ 180.5k
Michael Farrell
Independent Director9.9yrsUS$342.52k0.0010%
$ 217.5k
Devdatt Kurdikar
Directorless than a yearkeine Datenkeine Daten
Sreelakshmi Kolli
Independent Director3.8yrsUS$382.35k0.00050%
$ 108.7k
Syed Jafry
Independent Director6.3yrsUS$367.52k0.0020%
$ 443.7k

6.3yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrener Vorstand: ZBHDie Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).